vs
AMERICAN BATTERY TECHNOLOGY Co（ABAT）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是AMERICAN BATTERY TECHNOLOGY Co的1.9倍（$9.1M vs $4.8M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -195.0%，领先134.6%），AMERICAN BATTERY TECHNOLOGY Co同比增速更快（1331.8% vs -49.9%）
美国电池技术公司（原美国电池金属公司）是2011年成立的美国本土电池回收科技初创企业。该公司采用湿法冶金工艺进行电池回收，并依托专属提取系统从原生资源中提炼电池生产所需的原材料，聚焦动力电池产业链绿色循环业务。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
ABAT vs PLX — 直观对比
营收规模更大
PLX
是对方的1.9倍
$4.8M
营收增速更快
ABAT
高出1381.7%
-49.9%
净利率更高
PLX
高出134.6%
-195.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.8M | $9.1M |
| 净利润 | $-9.3M | $-5.5M |
| 毛利率 | -33.6% | 49.4% |
| 营业利润率 | -207.5% | -51.1% |
| 净利率 | -195.0% | -60.3% |
| 营收同比 | 1331.8% | -49.9% |
| 净利润同比 | 30.7% | -184.8% |
| 每股收益（稀释后） | $-0.07 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABATPLX
| Q4 25 | $4.8M | $9.1M | ||
| Q3 25 | $937.6K | $17.9M | ||
| Q2 25 | $2.8M | $15.7M | ||
| Q1 25 | $980.0K | $10.1M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | — | $18.0M | ||
| Q2 24 | — | $13.5M | ||
| Q4 23 | — | $10.5M |
净利润ABATPLX
| Q4 25 | $-9.3M | $-5.5M | ||
| Q3 25 | $-10.3M | $2.4M | ||
| Q2 25 | $-10.2M | $164.0K | ||
| Q1 25 | $-11.5M | $-3.6M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-2.2M | ||
| Q4 23 | — | $-6.0M |
毛利率ABATPLX
| Q4 25 | -33.6% | 49.4% | ||
| Q3 25 | -375.1% | 53.4% | ||
| Q2 25 | -92.6% | 62.5% | ||
| Q1 25 | -274.5% | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q4 23 | — | 15.5% |
营业利润率ABATPLX
| Q4 25 | -207.5% | -51.1% | ||
| Q3 25 | -1080.8% | 11.9% | ||
| Q2 25 | -280.1% | 7.5% | ||
| Q1 25 | -1086.3% | -41.0% | ||
| Q4 24 | — | 39.6% | ||
| Q3 24 | — | 22.2% | ||
| Q2 24 | — | -18.0% | ||
| Q4 23 | — | -53.5% |
净利率ABATPLX
| Q4 25 | -195.0% | -60.3% | ||
| Q3 25 | -1098.5% | 13.2% | ||
| Q2 25 | -366.4% | 1.0% | ||
| Q1 25 | -1173.1% | -35.8% | ||
| Q4 24 | — | 35.6% | ||
| Q3 24 | — | 18.0% | ||
| Q2 24 | — | -16.4% | ||
| Q4 23 | — | -57.6% |
每股收益（稀释后）ABATPLX
| Q4 25 | $-0.07 | $-0.06 | ||
| Q3 25 | $-0.09 | $0.03 | ||
| Q2 25 | $-0.09 | $0.00 | ||
| Q1 25 | $-0.14 | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q4 23 | — | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.9M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $119.0M | $48.2M |
| 总资产 | $123.3M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABATPLX
| Q4 25 | $47.9M | $14.7M | ||
| Q3 25 | $30.9M | $13.6M | ||
| Q2 25 | $7.5M | $17.9M | ||
| Q1 25 | $7.8M | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q4 23 | — | $23.6M |
股东权益ABATPLX
| Q4 25 | $119.0M | $48.2M | ||
| Q3 25 | $96.0M | $52.9M | ||
| Q2 25 | $70.6M | $49.9M | ||
| Q1 25 | $65.6M | $45.2M | ||
| Q4 24 | — | $43.2M | ||
| Q3 24 | — | $32.4M | ||
| Q2 24 | — | $28.6M | ||
| Q4 23 | — | $33.6M |
总资产ABATPLX
| Q4 25 | $123.3M | $82.3M | ||
| Q3 25 | $101.5M | $82.3M | ||
| Q2 25 | $84.5M | $78.5M | ||
| Q1 25 | $76.5M | $73.9M | ||
| Q4 24 | — | $73.4M | ||
| Q3 24 | — | $61.6M | ||
| Q2 24 | — | $91.5M | ||
| Q4 23 | — | $84.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流ABATPLX
| Q4 25 | $-9.8M | $2.0M | ||
| Q3 25 | $-7.1M | $-3.7M | ||
| Q2 25 | — | $-5.2M | ||
| Q1 25 | $-10.3M | $-5.1M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $-3.6M | ||
| Q4 23 | — | $3.6M |
自由现金流ABATPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q4 23 | — | $3.3M |
自由现金流率ABATPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q4 23 | — | 31.9% |
资本支出强度ABATPLX
| Q4 25 | — | 4.4% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q4 23 | — | 2.4% |
现金转化率ABATPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABAT
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
